SETD5

SET domain containing 5, the group of SET domain containing

Basic information

Region (hg38): 3:9397614-9479240

Links

ENSG00000168137 ∙ NCBI:55209 ∙ OMIM:615743 ∙ HGNC:25566 ∙ Uniprot:Q9C0A6 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

• intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency (Definitive), mode of inheritance: AD
• intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency (Supportive), mode of inheritance: AD
• intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency (Strong), mode of inheritance: AD
• syndromic complex neurodevelopmental disorder (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

Condition	Inheritance	Intervention Categories	Intervention/Rationale	Manifestation Categories	References
Intellectual developmental disorder, autosomal dominant 23	AD	General	Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing	Craniofacial; Musculoskeletal; Neurologic	24680889

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SETD5 gene.

• not provided (681 variants)
• Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency (129 variants)
• Inborn genetic diseases (67 variants)
• not specified (30 variants)
• SETD5-related condition (17 variants)
• See cases (6 variants)
• Intellectual disability (5 variants)
• Neurodevelopmental disorder (3 variants)
• Global developmental delay (2 variants)
• Developmental disorder (2 variants)
• Moyamoya angiopathy with developmental delay (2 variants)
• SETD5-related disorders (1 variants)
• SETD5-related syndromic intellectual disability (1 variants)
• Hyperphosphatasia with intellectual disability syndrome 4 (1 variants)
• SETD5-Related Disorder (1 variants)
• Microcephaly (1 variants)
• Neurodevelopmental delay (1 variants)
• Autism spectrum disorder (1 variants)
• Autistic behavior (1 variants)
• Cornelia de Lange-like syndrome (1 variants)
• Non-syndromic intellectual disability;Syndromic intellectual disability (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SETD5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous			6	99	14	119
missense	3	10	305	65	7	390
nonsense	39	11	1			51
start loss						0
frameshift	67	18	3			88
inframe indel			7	1		8
splice donor/acceptor (+/-2bp)	7	7	2			16
splice region	2	1	17	18		38
non coding			5	46	33	84
Total	116	46	329	211	54

Variants in SETD5

This is a list of pathogenic ClinVar variants found in the SETD5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position	Type	Phenotype	Significance	ClinVar
3-9428935-C-T			Uncertain significance (Jan 10, 2022)
3-9428937-T-C			Uncertain significance (Dec 19, 2022)
3-9428946-T-C			Uncertain significance (Feb 08, 2023)
3-9428948-G-T			Uncertain significance (Jun 06, 2023)
3-9428951-A-G		Inborn genetic diseases	Conflicting classifications of pathogenicity (Dec 27, 2023)
3-9428952-T-A			Likely benign (Sep 14, 2022)
3-9428957-C-G		SETD5-related disorder	Uncertain significance (Jun 09, 2023)
3-9428963-G-T		Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency	Uncertain significance (May 21, 2020)
3-9428969-A-G			Uncertain significance (Jan 25, 2024)
3-9428973-C-T			Uncertain significance (Dec 06, 2023)
3-9428989-A-G		not specified	Uncertain significance (May 04, 2022)
3-9429005-T-G			Uncertain significance (Feb 04, 2022)
3-9429012-A-G		See cases	Uncertain significance (Sep 14, 2021)
3-9429028-G-A			Likely benign (Oct 13, 2023)
3-9433832-C-T			Likely benign (Jul 20, 2023)
3-9433833-G-A			Likely benign (May 05, 2023)
3-9433836-T-C			Likely benign (Apr 06, 2023)
3-9433846-C-G		Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency	Uncertain significance (Feb 14, 2019)
3-9433860-G-A			Likely benign (May 01, 2022)
3-9433886-G-A			Uncertain significance (Jul 13, 2022)
3-9433889-T-G		SETD5-related syndromic intellectual disability	Uncertain significance (Dec 16, 2020)
3-9433896-C-A			Benign/Likely benign (Dec 07, 2022)
3-9433901-A-G		Inborn genetic diseases	Likely benign (May 17, 2021)
3-9433914-C-T			Likely benign (Dec 06, 2022)
3-9433923-G-C			Uncertain significance (Sep 19, 2023)

GnomAD

Source: gnomAD

Gene	Type	Bio Type	Transcript	Coding Exons	Length
SETD5	protein_coding	protein_coding	ENST00000402198	21	81626

pLI Probability LOF Intolerant	pRec Probability LOF Recessive	Individuals with no LOFs	Individuals with Homozygous LOFs	Individuals with Heterozygous LOFs	Defined	p
1.00	0.0000298	124610	0	32	124642	0.000128

	Z-Score	Observed	Expected	Observed/Expected	Mutation Rate	Total Possible in Transcript
Missense	1.13	683	772	0.885	0.0000430	9258
Missense in Polyphen		177	311.9	0.56748		3567
Synonymous	-0.684	296	281	1.05	0.0000144	2959
Loss of Function	6.70	9	69.1	0.130	0.00000434	803

LoF frequencies by population

Ethnicity	Sum of pLOFs	p
African & African-American	0.00106	0.00106
Ashkenazi Jewish	0.000201	0.000199
East Asian	0.000111	0.000111
Finnish	0.0000464	0.0000464
European (Non-Finnish)	0.0000355	0.0000354
Middle Eastern	0.000111	0.000111
South Asian	0.000132	0.000131
Other	0.000333	0.000330

dbNSFP

Source: dbNSFP

• Function: FUNCTION: Probable transcriptional regulator that acts via the formation of large multiprotein complexes that modify and/or remodel the chromatin. Acts as a regulator of histone acetylation during gene transcription. {ECO:0000250|UniProtKB:Q5XJV7}.
• Disease: DISEASE: Mental retardation, autosomal dominant 23 (MRD23) [MIM:615761]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD23 patients manifest moderate to severe intellectual disability with additional variable features of brachycephaly, a low hairline, depressed nasal bridge, prominent high nasal root, tubular nose, upslanting palpebral fissures, long and smooth philtrum, micrognathia, thin upper lip, and crowded teeth. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, are prominent features. {ECO:0000269|PubMed:24680889, ECO:0000269|PubMed:25138099, ECO:0000269|PubMed:27375234, ECO:0000269|PubMed:28549204}. Note=The disease is caused by mutations affecting the gene represented in this entry.
• Pathway: Histone Modifications (Consensus)

Recessive Scores

• pRec: 0.107

Intolerance Scores

• loftool: 0.0174
• rvis_EVS: -0.79
• rvis_percentile_EVS: 12.6

Haploinsufficiency Scores

• pHI: 0.467
• hipred: N
• hipred_score: 0.481
• ghis: 0.653

Essentials

• essential_gene_CRISPR: N
• essential_gene_CRISPR2: N
• gene_indispensability_pred: E
• gene_indispensability_score: 0.797

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Medium	Medium
Primary Immunodeficiency	Medium	Medium	Medium
Cancer	Medium	Medium	Medium

Mouse Genome Informatics

• Gene name: Setd5
• Phenotype: growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; skeleton phenotype; renal/urinary system phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype

Zebrafish Information Network

• Gene name: setd5
• Affected structure: head
• Phenotype tag: abnormal
• Phenotype quality: decreased size

Gene ontology

• Biological process: covalent chromatin modification;regulation of histone acetylation;regulation of chromatin organization
• Cellular component: nucleus;nucleoplasm;Cdc73/Paf1 complex